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Sir—I read with great interest the meta-analysis “Obesity in 
total hip arthroplasty—does it really matter?” by Haverkamp 
et al. published in the August 2011 issue. However, it seems 
to me that there is an error in their analysis regarding the out-
come “aseptic loosening”.
Figure 4. Forest plot aseptic loosening (below) contains 
wrong numbers producing a wrong overall result and wrong 
study conclusions with respect to revision for aseptic loosen-
ing (abstract and result section).
The numbers in the study by McLaughlin et al. (2006) 
should  read:  71  –  109  –  56  –  100.  (I  assume  that  the  column              
“Experimental” should read “BMI < 30” and the column 
“Control” “BMI > 30” as in the other figures).         
The resulting OR for this study should then be 1.16 (95% 
CI 0.9; 1.5) instead of 0.45. And as a consequence, the total 
events and total OR are incorrect as well.
Furthermore, there are three other issues I would like to 
address:
1. The study by Andrew et al. (2008) included in the analy-
sis for Figure 4 does not specify the reason for revision, and 
the numbers of revision indicated here (14 in non-obese and 5 
in obese) can theoretically also contain cases with revision for 
septic loosening, dislocation or other.
2. A large study (n = 2026 primary THAs) conducted by 
Jackson et al. (2009) with the title “The effect of obesity on 
the midterm survival and clinical outcome of cementless total 
hip replacement” has not been included in the meta-analysis.
3. The authors write in their discussion (page 441, 2. Para-
graph): “Previous studies have suggested that dislocation 
occurs more often in obese people (Paterno et al. 1997, Sadr 
et al. 2008).”  However, the study by Paterno et al. does not 
report on a higher risk in obese. He found a  dislocation risk of 
3% in obese vs.  5% in non-obese patients. To the best of my 
knowledge the studies by Lübbeke et al. (2007) and Sadr et al. 
(2008) were the first to demonstrate a significantly higher rate 
of dislocation in obese patients.
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Sir—We would like to thank Dr Lübbeke for her critical anal-
ysis of our manuscript. The main concern is the interpretation 
of the aseptic loosening in our meta-analysis and our conclu-
sion regarding the occurrence of aseptic loosening in obese 
compared to non obese. 
The study of McLaughin et al. (2006) shows no difference 
between obese and non-obese with regard to the long term 
outcome, however in both groups more than 55% were revised 
for loosening at the time of analysis. We agree that we made 
a mistake in the data extraction, and that the Mclaughin study 
was not correctly cited. The small difference that seems to be 
in the disadvantage of the obese disappears, the correct odds 
ratio is 1.2 (95% CI 0.78–1.8). Since the study of Mclaughin 
has 50% of the weight in our comparison, based on the large 
number of revisions, we also made an analysis without this 
study showing a similar outcome (OR 0.97 (95%CI: 0.53–
1.77). Therefore it cannot be said that obese have a higher risk 
of revision for aseptic loosening as stated earlier. 
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In the study of Andrew et al. (2008) it is correct that the 
reason for revision is not specified as being aseptic, however 
all the complications like deep infection and dislocation are 
mentioned separately and for none it is mentioned that this 
resulted in a revision surgery. Based on a critical analysis of 
this manuscript we assumed that the revisions mentioned were 
performed for aseptic loosening. Leaving this study out of the 
pooling did not change the abovementioned outcome. 
The study of Jackson et al. (2009) concerns the survival of 
THA in the obese compared to the none obese and this study 
appears valid to be included in our analysis. Data extraction 
results in 8 revisions in 1,652 (0.5%) non-obese and 3 revi-
sions in 414 (0.7%) obese for aseptic loosening. Including this 
in the meta-analysis changes OR to 1.1 (0.8–1.7). 
The main concern of Dr Lübbeke is correct, we cannot prove 
a difference in aseptic loosening in obese versus non-obese. 
Based on the current evidence it cannot be excluded either. 
The main concern is the large heterogeneity between the stud-
ies; comparing revision rates of 65% (McLaughin) and 0.5% 
(Jackson) is difficult. 
Regarding the last remark, we obviously cited the wrong 
article in the discussion. While Lübbeke et al. and Sadr et al. 
are mentioned in the text and should be cited, we cited Paterno 
instead of Lübbeke. Of course Dr Lübbeke was the first to 
show the difference in dislocation rate between obese and 
non-obese. 
The main outcome of our study was a higher infection rate 
in obese compared to non-obese and a higher dislocation rate 
in obese, no doubt about this. Regarding the occurrence of 
aseptic loosening we did not find a difference between obese 
and non-obese.
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